115 related articles for article (PubMed ID: 30659195)
1. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.
Xiong L; Wu F; Wu Q; Xu L; Cheung OK; Kang W; Mok MT; Szeto LLM; Lun CY; Lung RW; Zhang J; Yu KH; Lee SD; Huang G; Wang CM; Liu J; Yu Z; Yu DY; Chou JL; Huang WH; Feng B; Cheung YS; Lai PB; Tan P; Wong N; Chan MW; Huang TH; Yip KY; Cheng AS; To KF
Nat Commun; 2019 Jan; 10(1):335. PubMed ID: 30659195
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
Wangensteen KJ; Wang YJ; Dou Z; Wang AW; Mosleh-Shirazi E; Horlbeck MA; Gilbert LA; Weissman JS; Berger SL; Kaestner KH
Hepatology; 2018 Aug; 68(2):663-676. PubMed ID: 29091290
[TBL] [Abstract][Full Text] [Related]
3. Gender Differences in Global but Not Targeted Demethylation in iPSC Reprogramming.
Milagre I; Stubbs TM; King MR; Spindel J; Santos F; Krueger F; Bachman M; Segonds-Pichon A; Balasubramanian S; Andrews SR; Dean W; Reik W
Cell Rep; 2017 Jan; 18(5):1079-1089. PubMed ID: 28147265
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for cell type specific DNA binding of C/EBPβ: The case of cell cycle inhibitor p15INK4b promoter.
Lountos GT; Cherry S; Tropea JE; Wlodawer A; Miller M
J Struct Biol; 2022 Dec; 214(4):107918. PubMed ID: 36343842
[TBL] [Abstract][Full Text] [Related]
5. High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription.
Bressin A; Jasnovidova O; Arnold M; Altendorfer E; Trajkovski F; Kratz TA; Handzlik JE; Hnisz D; Mayer A
Nat Commun; 2023 Aug; 14(1):4971. PubMed ID: 37591883
[TBL] [Abstract][Full Text] [Related]
6. Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities.
Dinh TA; Sritharan R; Smith FD; Francisco AB; Ma RK; Bunaciu RP; Kanke M; Danko CG; Massa AP; Scott JD; Sethupathy P
Cell Rep; 2020 Apr; 31(2):107509. PubMed ID: 32294439
[TBL] [Abstract][Full Text] [Related]
7. A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma.
Zhou RW; Xu J; Martin TC; Zachem AL; He J; Ozturk S; Demircioglu D; Bansal A; Trotta AP; Giotti B; Gryder B; Shen Y; Wu X; Carcamo S; Bosch K; Hopkins B; Tsankov A; Steinhagen R; Jones DR; Asara J; Chipuk JE; Brody R; Itzkowitz S; Chio IIC; Hasson D; Bernstein E; Parsons RE
Nat Commun; 2022 Oct; 13(1):6041. PubMed ID: 36253360
[TBL] [Abstract][Full Text] [Related]
8. Bookmarking by Non-pioneer Transcription Factors during Liver Development Establishes Competence for Future Gene Activation.
Karagianni P; Moulos P; Schmidt D; Odom DT; Talianidis I
Cell Rep; 2020 Feb; 30(5):1319-1328.e6. PubMed ID: 32023452
[TBL] [Abstract][Full Text] [Related]
9. CDCA7-associated global aberrant DNA hypomethylation translates to localized, tissue-specific transcriptional responses.
Vukic M; Chouaref J; Della Chiara V; Dogan S; Ratner F; Hogenboom JZM; Epp TA; Chawengsaksophak K; Vonk KKD; Breukel C; Ariyurek Y; San Leon Granado D; Kloet SL; Daxinger L
Sci Adv; 2024 Feb; 10(6):eadk3384. PubMed ID: 38335290
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific DNA methylation loss during ageing and carcinogenesis is linked to chromosome structure, replication timing and cell division rates.
Dmitrijeva M; Ossowski S; Serrano L; Schaefer MH
Nucleic Acids Res; 2018 Aug; 46(14):7022-7039. PubMed ID: 29893918
[TBL] [Abstract][Full Text] [Related]
11. Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens.
Lopes R; Sprouffske K; Sheng C; Uijttewaal ECH; Wesdorp AE; Dahinden J; Wengert S; Diaz-Miyar J; Yildiz U; Bleu M; Apfel V; Mermet-Meillon F; Krese R; Eder M; Olsen AV; Hoppe P; Knehr J; Carbone W; Cuttat R; Waldt A; Altorfer M; Naumann U; Weischenfeldt J; deWeck A; Kauffmann A; Roma G; Schübeler D; Galli GG
Sci Adv; 2021 Jul; 7(27):. PubMed ID: 34215580
[TBL] [Abstract][Full Text] [Related]
12. Dynamic DNA 5-hydroxylmethylcytosine and RNA 5-methycytosine Reprogramming During Early Human Development.
Han X; Guo J; Wang M; Zhang N; Ren J; Yang Y; Chi X; Chen Y; Yao H; Zhao YL; Yang YG; Sun Y; Xu J
Genomics Proteomics Bioinformatics; 2023 Aug; 21(4):805-822. PubMed ID: 35644351
[TBL] [Abstract][Full Text] [Related]
13. Mapping and predicting gene-enhancer interactions.
Gaffney DJ
Nat Genet; 2019 Dec; 51(12):1662-1663. PubMed ID: 31784730
[No Abstract] [Full Text] [Related]
14. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM
Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918
[TBL] [Abstract][Full Text] [Related]
15. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule targeting of brachyury transcription factor addiction in chordoma.
Sharifnia T; Wawer MJ; Chen T; Huang QY; Weir BA; Sizemore A; Lawlor MA; Goodale A; Cowley GS; Vazquez F; Ott CJ; Francis JM; Sassi S; Cogswell P; Sheppard HE; Zhang T; Gray NS; Clarke PA; Blagg J; Workman P; Sommer J; Hornicek F; Root DE; Hahn WC; Bradner JE; Wong KK; Clemons PA; Lin CY; Kotz JD; Schreiber SL
Nat Med; 2019 Feb; 25(2):292-300. PubMed ID: 30664779
[TBL] [Abstract][Full Text] [Related]
17. C1 CAGE detects transcription start sites and enhancer activity at single-cell resolution.
Kouno T; Moody J; Kwon AT; Shibayama Y; Kato S; Huang Y; Böttcher M; Motakis E; Mendez M; Severin J; Luginbühl J; Abugessaisa I; Hasegawa A; Takizawa S; Arakawa T; Furuno M; Ramalingam N; West J; Suzuki H; Kasukawa T; Lassmann T; Hon CC; Arner E; Carninci P; Plessy C; Shin JW
Nat Commun; 2019 Jan; 10(1):360. PubMed ID: 30664627
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
Zhang Z; Lee JH; Ruan H; Ye Y; Krakowiak J; Hu Q; Xiang Y; Gong J; Zhou B; Wang L; Lin C; Diao L; Mills GB; Li W; Han L
Nat Commun; 2019 Oct; 10(1):4562. PubMed ID: 31594934
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
20. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma.
Chen YR; Ouyang SS; Chen YL; Li P; Xu HW; Zhu SL
Aging (Albany NY); 2020 Sep; 12(17):17541-17567. PubMed ID: 32927435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
